DJ Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Quest Diagnostics Inc. $(DGX)$ slid 1.71% to $172.01 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.12% to 5,842.63 and the Dow Jones Industrial Average rising 1.14% to 43,006.59.
This was the stock's second consecutive day of losses.
Quest Diagnostics Inc. closed 3.41% short of its 52-week high of $178.09, which the company achieved on March 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. $(UNH)$ rose 0.29% to $475.98, IQVIA Holdings Inc. $(IQV)$ rose 1.24% to $185.85, and Centene Corp. $(CNC)$ rose 1.95% to $59.00.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 05, 2025 17:09 ET (22:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。